Aurobindo Pharma to sell Natrol to New Mountain Capital for $550 mn
Aurobindo Pharma to divest US-based subsidiary Natrol to New Mountain Capital New Mountain Capital acquired profitable Natrol at $550 mn. ...
Aurobindo Pharma to divest US-based subsidiary Natrol to New Mountain Capital New Mountain Capital acquired profitable Natrol at $550 mn. ...
THD NewsDesk, Hyderabad: On September 15th, The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited declared a ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily